Sparsentan: Sparsentan- A novel, non- immunosuppressive, dual action angiotensin II and endothelin A receptor antagonist -A new hope for glomerular disease. (2024). Journal of Shaheed Suhrawardy Medical College, 14(2), 58-62. https://doi.org/10.3329/jssmc.v14i2.73180